Skip to content
Screener

Avalo Therapeutics AVTX Maryland — Increase (Decrease) in Operating Lease Liability

Similar metrics at other companies

Opendoor Technologies Inc logo
OPENTempe, Arizona Office — Increase (Decrease) in Operating Lease Liability
-$7M
Monte Rosa Therapeutics, Inc. logo
GLUEKlybeckstrasse Lease — Increase Decrease In Operating Lease Liability
$1M
EyePoint, Inc. logo
EYPTWatertown Massachusetts — Increase Decrease In Operating Lease Liability
$600K
Clearfield logo
CLFDBrooklyn Park MN — Increase Decrease In Operating Lease Liability
$3.55M
SharkNinja logo
SNIncrease Decrease In Operating Lease Liability
-$5.28M-19.9%
SLD
SLDPIncrease Decrease In Operating Lease Liability
-$230K+39.2%

Other financials

Income statement

See full
Revenue$59.0K-69.3%
Gross profit$963.0K+8,855%
Operating income-$31.5M-63.2%
Net income-$36.4M-75.1%
EPS (diluted)-$0.83+56.8%

Balance sheet

See full
Cash & equivalents$85.6M+101%
Total debt$242.0K-64.4%
Total equity$448.7M+329%
Total assets$490.8M+288%

Cash flow

See full
Operating cash flow-$20.0M-75.5%
CapEx-
Free cash flow-$15.0M-444%

Valuation

See full
Market cap$1.06B+987%
Enterprise value$974.89M+1,651%

Profitability

See full
Gross margin182%+176pp
Operating margin-15,536.1%-17,275pp
Net margin-7,965.8%-10,750pp
FCF margin-11,123.8%-13,374pp

Returns & leverage

See full
Return on equity-36.3%
Debt / equity0.0×
Current ratio19.3×+6.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The source filing: Avalo Therapeutics’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 7:02 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001534120-26-000033

Additionally, Avalo had an operating lease for administrative office space in Rockville, Maryland, which the Company elected to early-terminate effective January 31, 2026 by providing notice and paying the $0.3 million contractual early termination fee in the fourth quarter of 2024, resulting in a remeasurement and reduction of the lease liability and right-of-use (“ROU”) asset by $0.3 million. The lease liability and lease payments related to the property continued through the early-termination date of January 31, 2026. The annual base rent for this office was $0.2 million and was subject to annual 2.5% increases over the term of the lease.

Item 1. Financial Statements.

FAQ

What is Avalo Therapeutics's maryland — increase (decrease) in operating lease liability?
Avalo Therapeutics (AVTX) reported maryland — increase (decrease) in operating lease liability of -$300K in Q1 2026.
How has Avalo Therapeutics's maryland — increase (decrease) in operating lease liability changed year-over-year?
Avalo Therapeutics's maryland — increase (decrease) in operating lease liability decreased by 0.0% year-over-year, from -$300K to -$300K.
What does maryland — increase (decrease) in operating lease liability mean?
The net change in the present value of future lease payments for operating leases associated with the Maryland geographic segment. This reflects adjustments due to new lease agreements, modifications, or the passage of time as the company manages its facility obligations.

Ask your AI about Avalo Therapeutics's maryland — increase (decrease) in operating lease liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude